Compounded Bioidentical Hormone Therapy Market - Top Companies and Manufacturers

Companies Dominating the Compounded Bioidentical Hormone Therapy Landscape

Biote Medical, LLC
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Neuva Aesthetics
Defy Medical, LLC
The biostation
Noven Pharmaceuticals, Inc.
Novartis AG
Pfizer Inc.
Novo Nordisk A/S
Therapeutics MD Inc
Bayer AG

Browse Key Market Insights with Data Illustration:

Compounded Bioidentical Hormone Therapy Market Report 2036

In the News

April 14, 2022: Therapeutics MD finalises the divestiture of vitaCare prescription services through USD 150 million cash transaction to focus solely on its women’s health portfolio.
September 26, 2018: The U.S. Food and Drug Administration announced an agreement with the National Academies of Science, Engineering and Medicine (NASEM) for conducting research examining the clinical use of compounded bioidentical hormonal replacement therapy (BHRT).

Frequently Asked Questions (FAQ)

The compounded bioidentical hormone therapy industry size is expected to register around 5.2% CAGR during the forecast period i.e., between 2024-2036.

The market growth is propelled by increasing health awareness amongst the people.

North America industry is estimated to account for largest revenue share by 2036, on the back of higher healthcare expenditure, increasing thyroid prevalence amongst women, and more awareness amongst the people.

The major players in the market are Defy Medical, LLC, The biostation, Noven Pharmaceuticals, Inc., Novartis AG, and Pfizer Inc.

Compounded Bioidentical Hormone Therapy Market - Top Companies and Manufacturers

Companies Dominating the Compounded Bioidentical Hormone Therapy Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the compounded bioidentical hormone therapy market worth?

Why is the demand for compounded bioidentical hormone therapy growing?

Which region dominated the majority of compounded bioidentical hormone therapy industry share?

Who are the top compounded bioidentical hormone therapy companies?